CEP55 and hepatocellular carcinoma: It has been reported that the interaction between CEP55 and SPAG5 triggered the phosphorylation of AKT at Ser473 and activated the PI3K/AKT pathway to exhibit pro-hepatocellular carcinoma activities (18).